YCM
SCLN

Yakira Capital Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Yakira Capital Management’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-85,500
Closed -$958K – 141
2017
Q3 		$958K Hold
85,500
– – 0.32% 59
2017
Q2 		$941K Buy
+85,500
New +$855K 0.28% 59

Yakira Capital Management's SCLN Position: Q4 2017 in Review

Yakira Capital Management sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 85,500 shares — an estimated $958K sold.

Yakira Capital Management first reported a position in SCLN in Q2 2017 and held it in 2 quarters. The position peaked at $958K in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • Yakira Capital Management reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Yakira Capital Management sold 85,500 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $958K.
  • Yakira Capital Management first reported a position in Sciclone Pharmaceuticals Inc in Q2 2017 and held it in 2 quarters.
  • Yakira Capital Management's Sciclone Pharmaceuticals Inc position peaked at $958K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Yakira Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.